Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Author(s) -
Changyu Zhu,
KyeongJin Kim,
Xiaobo Wang,
Alberto Bartolomé,
Marcela Salomao,
Paola Dongiovanni,
Marica Meroni,
Mark J. Graham,
Katherine P. Yates,
Anna Mae Diehl,
Robert F. Schwabe,
Ira Tabas,
Luca Valenti,
Joel E. Lavine,
Utpal B. Pajvani
Publication year - 2018
Publication title -
science translational medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aat0344
Subject(s) - fibrosis , hepatocyte , steatohepatitis , nonalcoholic fatty liver disease , cirrhosis , medicine , fatty liver , liver function , liver disease , pathology , biology , endocrinology , disease , biochemistry , in vitro
Aberrant hepatocyte Notch activation is required for development of NASH-associated fibrosis, and Notch inhibition ameliorates obesity-induced liver disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom